Baldapan, Joana .
HRN: 23-58-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/15/2025
03/31/2025
IVT
270mg
Q6
PCAP-D
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes